US 11629334
Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
granted A61KA61K2239/57A61K38/1703
Quick answer
US patent 11629334 (Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2239/57, A61K38/1703, A61K40/11, A61K40/32